Lower bone turnover markers in metabolic syndrome and diabetes: The population-based Study of Health in Pomerania

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 25, Issue 5, 2015, Pages 458-463

  Lerchbaum, E ^a,b   Schwetz, V ^a   Nauck, M ^c   Volzke H ^c   Wallaschofski, H ^c   Hannemann, A ^c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

25 hydroxyvitamin D; Beta crosslaps; Osteocalcin; Procollagen type 1N terminal propeptide

Indexed keywords

25 HYDROXYVITAMIN D; BETA LACTAMASE CTX M; BIOLOGICAL MARKER; BONE TURNOVER MARKER; OSTEOCALCIN; PARATHYROID HORMONE; UNCLASSIFIED DRUG; 25-HYDROXYVITAMIN D; COLLAGEN; GLUTAMYL-LYSYL-ALANYL-HISTIDYL-ASPARTYL-GLYCYL-GLYCYL-ARGININE; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE I CARBOXY TERMINAL PEPTIDE; PTH PROTEIN, HUMAN; VITAMIN D;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; BONE METABOLISM; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYSICAL EXAMINATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; VERY ELDERLY; ANALOGS AND DERIVATIVES; BLOOD; BONE REMODELING; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; DOWN REGULATION; GERMANY; METABOLISM; PREVALENCE; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; BONE REMODELING; COHORT STUDIES; COLLAGEN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PREVALENCE; PROCOLLAGEN; VITAMIN D; YOUNG ADULT;

EID: 84927796521     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2015.02.002     Document Type: Article

References (30)

1. Schwetz V., Pieber T., Obermayer-Pietsch B. The endocrine role of the skeleton: background and clinical evidence. Eur J Endocrinol 2012, 166:959-967.
2. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
3. Pludowski P., Holick M.F., Pilz S., Wagner C.L., Hollis B.W., Grant W.B., et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 2013, 12:976-989.
4. Khan H., Kunutsor S., Franco O.H., Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc 2013, 72:89-97.
5. Hernandez J.L., Olmos J.M., Pariente E., Martinez J., Valero C., Garcia-Velasco P., et al. Metabolic syndrome and bone metabolism: the Camargo Cohort Study. Menopause 2010, 17:955-961.
6. Bezerra dos Santos Magalhaes K., Magalhaes M.M., Diniz E.T., Lucena C.S., Griz L., Bandeira F. Metabolic syndrome and central fat distribution are related to lower serum osteocalcin concentrations. Ann Nutr Metab 2013, 62:183-188.
7. Dobnig H., Piswanger-Solkner J.C., Roth M., Obermayer-Pietsch B., Tiran A., Strele A., et al. Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab 2006, 91:3355-3363.
8. Gerdhem P., Isaksson A., Akesson K., Obrant K.J. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 2005, 16:1506-1512.
9. Larsen K.I., Falany M.L., Ponomareva L.V., Wang W., Williams J.P. Glucose-dependent regulation of osteoclast H(+)-ATPase expression: potential role of p38 MAP-kinase. J Cell Biochem 2002, 87:75-84.
10. Lerchbaum E., Schwetz V., Pilz S., Boehm B.O., Marz W. Association of bone turnover markers with mortality in women referred to coronary angiography: the Ludwigshafen risk and Cardiovascular health (LURIC) study. Osteoporos Int 2014, 25:455-465.
11. Okazaki R., Totsuka Y., Hamano K., Ajima M., Miura M., Hirota Y., et al. Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab 1997, 82:2915-2920.
12. Pittas A.G., Harris S.S., Eliades M., Stark P., Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009, 94:827-832.
13. Volzke H., Alte D., Schmidt C.O., Radke D., Lorbeer R., Friedrich N., et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol 2010, 40:294-307.
14. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
15. Lerchbaum E., Schwetz V., Pilz S., Grammer T.B., Look M., Boehm B.O., et al. Association of bone turnover markers with mortality in men referred to coronary angiography. Osteoporos Int 2013, 24:1321-1332.
16. Verhaeghe J., van Herck E., Visser W.J., Suiker A.M., Thomasset M., Einhorn T.A., et al. Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 1990, 39:477-482.
17. Szulc P., Varennes A., Delmas P.D., Goudable J., Chapurlat R. Men with metabolic syndrome have lower bone mineral density but lower fracture risk-the MINOS study. J Bone Min Res 2010, 25:1446-1454.
18. Oosterwerff M.M., van Schoor N.M., Lips P., Eekhoff E.M. Osteocalcin as a predictor of the metabolic syndrome in older persons: a population-based study. Clin Endocrinol (Oxf) 2013, 78:242-247.
19. Yeap B.B., Chubb S.A., Flicker L., McCaul K.A., Ebeling P.R., Beilby J.P., et al. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol 2010, 163:265-272.
20. Schwetz V., Lerchbaum E., Schweighofer N., Hacker N., Trummer O., Borel O., et al. Osteocalcin levels on oral glucose load in women being investigated for polycystic ovary syndrome. Endocr Pract 2014, 20:5-14.
21. Kunutsor S.K., Apekey T.A., Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol 2013, 28:205-221.
22. Hintzpeter B., Mensink G.B., Thierfelder W., Muller M.J., Scheidt-Nave C. Vitamin D status and health correlates among German adults. Eur J Clin Nutr 2008, 62:1079-1089.
23. Roislien J., Van Calster B., Hjelmesaeth J. Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study. Cardiovasc Diabetol 2011, 10:17.
24. Guasch A., Bullo M., Rabassa A., Bonada A., Del Castillo D., Sabench F., et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovasc Diabetol 2012, 11:149.
25. Rueda S., Fernandez-Fernandez C., Romero F., Martinez de Osaba J., Vidal J. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 2008, 18:151-154.
26. Reis J.P., von Muhlen D., Kritz-Silverstein D., Wingard D.L., Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007, 30:1549-1555.
27. ESHRE Capri Workshop Group ECW Perimenopausal risk factors and future health. Hum Reprod Update 2011, 17:706-717.
28. Mithal A., Wahl D.A., Bonjour J.P., Burckhardt P., Dawson-Hughes B., Eisman J.A., et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009, 20:1807-1820.
29. Lecka-Czernik B. Bone as a target of type 2 diabetes treatment. Curr Opin Investig Drugs 2009, 10:1085-1090.
30. Carnevale V., Romagnoli E., D'Erasmo L., D'Erasmo E. Bone damage in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2014, 24:1151-1157.